A Therapeutic Challenge in Pediatric Atopic Dermatitis: Off-Label Upadacitinib Following Suspected Dupilumab-Associated Alopecia Areata (ACAAI 2026) - Oct 28, 2026 - Abstract #M750; Pres time: Nov 14, 2026; 12:20 PM - 01:00 PM; Location: Phoenix Convention Center • North Halls 4–6 (Lower Level); Monitor 10; No abstract available
Clinical • Alopecia • Atopic Dermatitis • Dermatitis • Dermatology • Immunology • Pediatrics
|